{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:43:44Z","timestamp":1761489824226},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Oncol."],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1093\/jjco\/hyv092","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T01:19:26Z","timestamp":1447377566000},"page":"13-22","source":"Crossref","is-referenced-by-count":18,"title":["Prevention of infection-related cancers in the WHO Western Pacific Region"],"prefix":"10.1093","volume":"46","author":[{"given":"Hai-Rim","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aesun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeongtaek","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ru","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherian","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"2015122801081110000_46.1.13.1","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens. Part B: Biological agents\/IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Lyon, France, 2009."},{"key":"2015122801081110000_46.1.13.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70137-7"},{"key":"2015122801081110000_46.1.13.3","doi-asserted-by":"crossref","unstructured":"Grellier N Quero L . Cervical cancer: particularities in HIV patients. Bull Cancer 2014;101:1040\u20137.","DOI":"10.1684\/bdc.2014.2034"},{"key":"2015122801081110000_46.1.13.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.06.020"},{"key":"2015122801081110000_46.1.13.5","doi-asserted-by":"crossref","unstructured":"Nutankalva L Wutoh AK McNeil J Malignancies in HIV: pre- and post-highly active antiretroviral therapy. J Natl Med Assoc 2008;100:817\u201320.","DOI":"10.1016\/S0027-9684(15)31375-4"},{"key":"2015122801081110000_46.1.13.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"2015122801081110000_46.1.13.7","unstructured":"GLOBOCAN 2012. http:\/\/globocan.iarc.fr\/Default.aspx (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.8","unstructured":"World Health Organization. Western Pacific Regional Action Plan for the Prevention and Control of NCDs (2014\u20132020). http:\/\/www.wpro.who.int\/noncommunicable_diseases\/about\/ncd_regional_action_plan_2014-2020\/en\/ (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.9","unstructured":"World Health Organization. NCD Country Capacity Survey, 2013. http:\/\/hiip.wpro.who.int\/portal\/Dashboards\/Noncommunicablediseases\/NCDdashboards\/TabId\/210\/ArtMID\/1088\/ArticleID\/202\/Default (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.10","unstructured":"World Health Organization. Viral hepatitis. http:\/\/www.who.int\/hiv\/topics\/hepatitis\/en\/ (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"2015122801081110000_46.1.13.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-131"},{"key":"2015122801081110000_46.1.13.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.027"},{"key":"2015122801081110000_46.1.13.14","unstructured":"Liu YB XJ Zhong CI Liu K . Hepatitis C virus infection among hemodialysis patients in Asia: a meta-analysis. Eur Rev Med Pharmacol Sci 2014;18:3174\u201382."},{"key":"2015122801081110000_46.1.13.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"2015122801081110000_46.1.13.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075586"},{"key":"2015122801081110000_46.1.13.17","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global Report: UNAIDS Report in the Global AIDS Epidemic 2013 Global Report: UNAIDS Report in the Global AIDS Epidemic. http:\/\/www.un.org\/youthenvoy\/2013\/08\/unaids-joint-united-nations-programme-on-hivaids\/ (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.18","doi-asserted-by":"crossref","unstructured":"Chen W Zheng R Zhang S Zhao P Zeng H Zou X . Report of cancer incidence and mortality in China, 2010. Ann Transl Med 2014;2:61.","DOI":"10.1111\/1759-7714.12098"},{"key":"2015122801081110000_46.1.13.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05784.x"},{"key":"2015122801081110000_46.1.13.20","unstructured":"Yang BH Xia JL Huang LW Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 2004;3:194\u20138."},{"key":"2015122801081110000_46.1.13.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-011-9791-y"},{"key":"2015122801081110000_46.1.13.22","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20100190"},{"key":"2015122801081110000_46.1.13.23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq592"},{"key":"2015122801081110000_46.1.13.24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr437"},{"key":"2015122801081110000_46.1.13.25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn597"},{"key":"2015122801081110000_46.1.13.26","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.484"},{"key":"2015122801081110000_46.1.13.27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21731"},{"key":"2015122801081110000_46.1.13.28","unstructured":"World Health Organization. Universal Access to Safe Blood Transfusion. http:\/\/www.who.int\/bloodsafety\/publications\/UniversalAccesstoSafeBT.pdf?ua=1 (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.29","unstructured":"World Health Organization. Blood Donor Counselling: Implementation Guidelines. http:\/\/www.who.int\/bloodsafety\/voluntary_donation\/Blooddonorcounselling.pdf (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.30","unstructured":"World Health Organization. WHO Managing Injection Safety. http:\/\/www.who.int\/injection_safety\/toolbox\/en\/ManagingInjectionSafety.pdf?ua=1 (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.31","unstructured":"World Health Organization. Infection Prevention and Control (IPC) Guidance Summary. http:\/\/apps.who.int\/iris\/bitstream\/10665\/131828\/1\/WHO_EVD_Guidance_IPC_14.1_eng.pdf (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.32","unstructured":"World Health Organization. Guidance on Prevention of Viral Hepatitis B and C among People Who Inject Drugs. 2012. http:\/\/apps.who.int\/iris\/bitstream\/10665\/75357\/1\/9789241504041_eng.pdf (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.33","unstructured":"World Health Organization. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action. http:\/\/www.who.int\/csr\/disease\/hepatitis\/GHP_framework.pdf?ua=1 (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.110"},{"key":"2015122801081110000_46.1.13.35","unstructured":"World Health Organization. Countries using Hepatitis B vaccine. http:\/\/www.who.int\/immunization\/topics\/hepatitis_b\/en\/index.html (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.36","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.059220"},{"key":"2015122801081110000_46.1.13.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.082"},{"key":"2015122801081110000_46.1.13.38","unstructured":"World Health Organization. http:\/\/www.wpro.who.int\/about\/regional_committee\/64\/resolutions\/WPR_RC64_R5_HepB_control.pdf?ua=1 (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60220-8"},{"key":"2015122801081110000_46.1.13.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"2015122801081110000_46.1.13.41","unstructured":"Center for Disease Control and Prevention. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6243a4.htm (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.42","unstructured":"Clinical trials.gov. http:\/\/www.clinicaltrials.gov\/ct2\/results?term=hepatitis+c+drugs&Search=Search (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.43","unstructured":"WHO\/UNICEF. WHO\/UNICEF Joint Reporting Form on Immunization. 2014. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/routine\/reporting\/reporting\/en\/ (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600688"},{"key":"2015122801081110000_46.1.13.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06188.x"},{"key":"2015122801081110000_46.1.13.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124725"},{"key":"2015122801081110000_46.1.13.47","unstructured":"UNAIDS . The Gap Report. http:\/\/www.unaids.org\/en\/resources\/documents\/2014\/20140716_UNAIDS_gap_report (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.48","unstructured":"World Health Organization Western Pacific Region. Hepatitis B Control Country Profiles 2013."},{"key":"2015122801081110000_46.1.13.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.046"},{"key":"2015122801081110000_46.1.13.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.048"},{"key":"2015122801081110000_46.1.13.51","doi-asserted-by":"publisher","DOI":"10.1086\/599332"},{"key":"2015122801081110000_46.1.13.52","unstructured":"Department of Health. Surveillance of Viral Hepatitis in Hong Kong - 2004 Update Report. 2005. http:\/\/www.hepatitis.gov.hk (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.53","doi-asserted-by":"publisher","DOI":"10.1159\/000076640"},{"key":"2015122801081110000_46.1.13.54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088829"},{"key":"2015122801081110000_46.1.13.55","unstructured":"Tan PE . Antenatal screening for hepatitis B in pregnant women. Malays J Pathol 1988;10:79\u201383."},{"key":"2015122801081110000_46.1.13.56","doi-asserted-by":"publisher","DOI":"10.2188\/jea.17.69"},{"key":"2015122801081110000_46.1.13.57","unstructured":"World Health Organization. WHO mongolia annual report 2011. http:\/\/www.wpro.who.int\/mongolia\/publications\/report\/en\/ (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.58","unstructured":"Chapman BA Burt MJ Frampton CM The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. N Z Med J 2000;113:394\u20136."},{"key":"2015122801081110000_46.1.13.59","unstructured":"Weir R Jennings L Young S Brunton C Murdoch D . National serosurvey of vaccine preventable diseases. Wellington, New Zealand: Ministry of Health, Public Health Services, 2009."},{"key":"2015122801081110000_46.1.13.60","doi-asserted-by":"crossref","unstructured":"Nemba K Babona DM Vince JD . Age-specific prevalence of hepatitis B surface antigenaemia in hospitalized children at Port Moresby, Papua New Guinea (a cross-sectional study with implications for the Hepatitis B Control Programme). Ann Trop Paediatr 1993;13:237\u201341.","DOI":"10.1080\/02724936.1993.11747652"},{"key":"2015122801081110000_46.1.13.61","unstructured":"Sanders RC Lewis D Dyke T Alpers MP . Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea. P N G Med J 1992;35:197\u2013201."},{"key":"2015122801081110000_46.1.13.62","doi-asserted-by":"crossref","unstructured":"Yamaguchi K Inaoka T Ohtsuka R HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey. Jpn J Cancer Res 1993;84:715\u20139.","DOI":"10.1111\/j.1349-7006.1993.tb02034.x"},{"key":"2015122801081110000_46.1.13.63","doi-asserted-by":"crossref","unstructured":"Wong SN Ong JP Labio ME Hepatitis B infection among adults in the Philippines: a national seroprevalence study. World J Hepatol 2013;5:214\u20139.","DOI":"10.4254\/wjh.v5.i4.214"},{"key":"2015122801081110000_46.1.13.64","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2013.28.4.413"},{"key":"2015122801081110000_46.1.13.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.057"},{"key":"2015122801081110000_46.1.13.66","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23496"},{"key":"2015122801081110000_46.1.13.67","doi-asserted-by":"crossref","unstructured":"Hipgrave DB Nguyen TV Vu MH Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg 2003;69:288\u201394.","DOI":"10.4269\/ajtmh.2003.69.288"},{"key":"2015122801081110000_46.1.13.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.11.004"},{"key":"2015122801081110000_46.1.13.69","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.203"},{"key":"2015122801081110000_46.1.13.70","doi-asserted-by":"crossref","unstructured":"Austin FJ Maguire T Miles JA . The occurrence of hepatitis B antigen and antibody in some population groups in the southwest Pacific region. Am J Trop Med Hyg 1974;23:489\u201394.","DOI":"10.4269\/ajtmh.1974.23.489"},{"key":"2015122801081110000_46.1.13.71","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181b20e93"},{"key":"2015122801081110000_46.1.13.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00080-3"},{"key":"2015122801081110000_46.1.13.73","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90288-P"},{"key":"2015122801081110000_46.1.13.74","doi-asserted-by":"crossref","unstructured":"Gust ID Dimitrakakis M Zimmet P . Studies on hepatitis B surface antigen and antibody in Nauru. I. Distribution amongst Nauruans. Am J Trop Med Hyg 1978;27:1030\u20136.","DOI":"10.4269\/ajtmh.1978.27.1206"},{"key":"2015122801081110000_46.1.13.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00226-3"},{"key":"2015122801081110000_46.1.13.76","unstructured":"Zhuang H Coulepis AG Gust ID Zimmet P Taylor R Nemaia HT . A cross sectional study of markers of hepatitis B infection in Niue. N Z Med J 1983;96:330\u20132."},{"key":"2015122801081110000_46.1.13.77","unstructured":"Mahoney F Woodruff B Auerbach S Progress on the elimination of hepatitis B virus transmission in Micronesia and American Samoa. Pac Health Dialog 1996;3:140\u20136."},{"key":"2015122801081110000_46.1.13.78","unstructured":"Paksoy N . Hepatitis B surface antigen among blood donors and antenatals in Western Samoa. N Z Med J 1988;101:549."},{"key":"2015122801081110000_46.1.13.79","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20791"},{"key":"2015122801081110000_46.1.13.80","unstructured":"Robinson T Bullen C Humphries W Hornell J Moyes C . The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection. N Z Med J 2005;118:U1345."},{"key":"2015122801081110000_46.1.13.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.051"},{"key":"2015122801081110000_46.1.13.82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02540.x"},{"key":"2015122801081110000_46.1.13.83","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12220"},{"key":"2015122801081110000_46.1.13.84","doi-asserted-by":"publisher","DOI":"10.1007\/BF02358675"},{"key":"2015122801081110000_46.1.13.85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01820.x"},{"key":"2015122801081110000_46.1.13.86","unstructured":"Nesdale A Baker M Gane E Hepatitis C infection in New Zealand: estimating the current and future prevalence and impact. New Zealand: Ministry of Health, Public Health Services, 2000."},{"key":"2015122801081110000_46.1.13.87","unstructured":"Korea Centers for Disease Control and Prevention. Diagnosed prevalence and risk factors of hepatitis C in Korea. http:\/\/www.cdc.go.kr\/CDC\/info\/CdcKrInfo0301.jsp?menuIds=HOME001-MNU1132-MNU1138-MNU0037-MNU1380&cid=22073 (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06726.x"},{"key":"2015122801081110000_46.1.13.89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2008.00586.x"},{"key":"2015122801081110000_46.1.13.90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01283.x"},{"key":"2015122801081110000_46.1.13.91","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-104"},{"key":"2015122801081110000_46.1.13.92","doi-asserted-by":"crossref","unstructured":"Garland S Brotherton J Stevens M Assessing HPV genotype prevalence in Australian women by indigenous ethnicity pre-vaccination. Sex Transm Infect 2011. p. A120\u20131.","DOI":"10.1136\/sextrans-2011-050108.53"},{"key":"2015122801081110000_46.1.13.93","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2796"},{"key":"2015122801081110000_46.1.13.94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019244"},{"key":"2015122801081110000_46.1.13.95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01161.x"},{"key":"2015122801081110000_46.1.13.96","doi-asserted-by":"crossref","unstructured":"Bae JH Lee SJ Kim CJ Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008;18:788\u201394.","DOI":"10.1111\/j.1525-1438.2007.00959.x"},{"key":"2015122801081110000_46.1.13.97","unstructured":"ICO Information Centre on HPV and Cancer. New Zealand Human Papillomavirus and Related Cancers, Fact Sheet 2013. http:\/\/www.hpvcentre.net\/statistics\/reports\/NZL_FS.pdf (24 November 2014, date last accessed)."},{"key":"2015122801081110000_46.1.13.98","doi-asserted-by":"publisher","DOI":"10.1186\/2049-9957-1-4"},{"key":"2015122801081110000_46.1.13.99","unstructured":"Derraik JG . The potential significance to human health associated with the establishment of the snail Melanoides tuberculata in New Zealand. N Z Med J 2008;121:25\u201332."},{"key":"2015122801081110000_46.1.13.100","unstructured":"Korea Centers for Disease Control and Prevention. National survey of intestinal parasitic infections in Korea, 8th Report. Public health weekly report, Korea Centers for Disease Control and Prevention, 2014."},{"key":"2015122801081110000_46.1.13.101","unstructured":"National Cancer Center. Attributable causes of cancer in Korea in the year 2009. 2013. Goyang-si, Republic of Korea."}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/46\/1\/13\/2389852\/hyv092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:14:26Z","timestamp":1718194466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/hyv092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,26]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1093\/jjco\/hyv092"],"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyv092","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}